Skip to the page
pepts.wiki

We are not doctors and nothing here is medical advice. Always consult a medical professional first. Why we say this

Animal and cell studiesStub

IGF-1 LR3

Long-acting IGF-1 analogue

An analogue of insulin-like growth factor 1 with low affinity for IGF binding proteins, used mainly as a cell culture reagent.

Reconstitution calculator

At a glance

Animal and cell studies

The published evidence is from animals and cells. Little or nothing is published from controlled trials in people.

This page is a stub

The wiki has this compound's identity from the My-Pepts library, its standing, and what PubMed holds for it. The article, with its studies read and cited, is not written yet. Until it is, the counts below say how much research exists, not what it found.

How strong is the evidence

How far it has climbed

Every medicine climbs the same ladder. Most compounds never reach the top, and where one stands says how much its claims can carry.

  1. Licensed medicine

    A regulator has reviewed the trials and licensed it for a named use.

  2. Phase 3

    Large randomized trials, often thousands of people, against placebo or a standard treatment.

  3. Phase 2

    Mid-sized trials that measure dose against effect in people with the condition.

  4. Phase 1 and early human studies

    First studies in people: safety, and how the body handles it.

  5. Cells and animals: IGF-1 LR3

    Laboratory and animal work. An animal result is not a result in people.

86
papers on PubMed
25
of them in people
0
randomized trials
2
reviews

A count says how much has been published, not what it found. Counted on PubMed: 2026-11-16

Handling and reconstitution

From powder to a measured sample

The same four steps for any lyophilized vial. Laboratory handling, not use in a person.

  1. 1. Read the vial

    The label gives the mass of peptide in the vial, in milligrams. That number is the start of every calculation.

  2. 2. Add the diluent

    A measured volume of diluent goes in slowly, down the glass. Swirl gently; shaking can damage a peptide.

  3. 3. Work out the strength

    Concentration is mass divided by volume: 10 mg in 2 mL is 5 mg per mL.

  4. 4. Measure the sample

    Volume is the mass wanted divided by the concentration. On a U-100 syringe, 1 mL is 100 units.

The calculator below does the arithmetic and shows its working.

As powder

General practice for lyophilized peptides: keep the sealed vial frozen or refrigerated, dry and away from light, and follow the supplier's certificate of analysis.

In solution

Once in solution a peptide is kept refrigerated and used within the period the supplier states. A vial drawn from more than once needs a preserved diluent such as bacteriostatic water.

This is general practice for lyophilized peptides, not data on IGF-1 LR3 itself. The batch's certificate of analysis and the supplier's sheet are the facts to go by. More on storage

Reconstitution calculator

Opens on vial sizes common for research peptides. Change any number. How the arithmetic works

Draw to

10 units

0.1 mL on a U-100 syringe

Concentration
2.5 mg/mL
Each unit holds
25 mcg
Samples in the vial
20
Sample
250 mcg

5 mg in 2 mL is 2.5 mg/mL. 250 mcg of that is 0.1 mL, which reads as 10 units. This is arithmetic for a vial of IGF-1 LR3; no amount here is a recommendation.

IGF-1 LR3: on PubMed

What PubMed held for IGF-1 LR3 on November 16, 2026. A count says how much a compound has been studied, not what the studies found: how to read these numbers.

86
papers
25
in humans
0
clinical trials
0
randomized trials
2012: 0 papers122013: 0 papers2014: 0 papers142015: 0 papers2016: 0 papers162017: 0 papers2018: 0 papers182019: 1 papers2020: 1 papers202021: 2 papers2022: 1 papers222023: 2 papers2024: 2 papers242025: 3 papers2026: 1 papers so far26
Papers per year, 2012 to 2026. The most in one year: 3.

Most relevant on PubMed

Listed by PubMed's own relevance ranking, trials and reviews first. The wiki has not read these into the article unless they are also among its sources.

  1. Intranasal long R3 insulin-like growth factor-1 treatment promotes amyloid plaque remodeling in cerebral cortex but fails to preserve cognitive function in male 5XFAD mice

    StudyEngel MG, Narayan S, Cui MH, et al. Journal of Alzheimer's disease : JAD, 2025. PMID 39610283

  2. Inhibition of activin-like kinase 4/5 attenuates cancer cachexia associated muscle wasting

    StudyLevolger S, Wiemer EAC, van Vugt JLA, et al. Scientific reports, 2019. PMID 31285507

  3. Action of long(R3)-insulin-like growth factor-1 on protein metabolism in beef heifers

    StudyHill RA, Hunter RA, Lindsay DB, et al. Domestic animal endocrinology, 1999. PMID 10370861

  4. Coronary vascular growth matches IGF-1-stimulated cardiac growth in fetal sheep

    StudyJonker SS, Giraud GD, Chang EI, et al. FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 2020. PMID 32573852

  5. Revolutionary decellularized Alstroemeria stem-based nerve conduit integrated with GelMA and controlled IGF-1 LR3 release for enhanced rat sciatic nerve regeneration

    StudyYavuz E, Sağır MS, Ercan A, et al. International journal of biological macromolecules, 2025. PMID 41015370

  6. IGF-1 LR3 does not promote growth in late-gestation growth-restricted fetal sheep

    StudyWhite A, Stremming J, Wesolowski SR, et al. American journal of physiology. Endocrinology and metabolism, 2025. PMID 39679943

Search used: ("long R3 IGF-I"[tiab] OR "LR3-IGF-I"[tiab] OR "IGF-1 LR3"[tiab] OR "long R3 insulin-like growth factor"[tiab]). Run it on PubMed

Research links

Also in GH axis

Sold in blends: IGF-1 LR3 + MOTS-c, Ipamorelin + CJC-1295 (No DAC) + IGF-1 LR3, Retatrutide + IGF-1 LR3